Functionalization and cellular uptake of boron carbide nanoparticles.: The first step toward T cell-guided boron neutron capture therapy

In this paper we present surface modification strategies of boron carbide nanoparticles, which allow for bioconjugation of the transacting transcriptional activator (TAT) peptide and fluorescent dyes. Coated nanoparticles can be translocated into murine EL4 thymoma cells and B16 F10 maligant melanoma cells in amounts as high as 0.3 wt.% and 1 wt.%, respectively. Neutron irradiation of a test system consisting of untreated 1316 cells mixed with B 16 cells loaded with boron carbide nanoparticles were found to inhibit the proliferative capacity of untreated cells, showing that cells loaded with boron-containing nanoparticles can hinder the growth of neighboring cells upon neutron irradiation. This could provide the first step toward a T cell-guided boron neutron capture therapy.